Whalegun
Home

Jazz Pharmaceuticals JAZZ paid Avenue Solutions $80K for lobbying in Q2 2023 · Health Issues, Medicare

Trade details

Type
Lobbying report
Amount
$80,000
Quarter
Q2 2023
Stock
Jazz Pharmaceuticals JAZZ
Client
Jazz Pharmaceuticals
Reported
23/07/19

Up 0.0% from last quarter

What else happened in Jazz Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/05/31~23/07/30

Jazz Pharmaceuticals's other lobbying reports

  • Jazz Pharmaceuticals

    LobbyingJazz Pharmaceuticals

    $80K

    Reported 07/20

  • Jazz Pharmaceuticals

    LobbyingJazz Pharmaceuticals

    $490K

    Reported 07/20

  • Jazz Pharmaceuticals

    LobbyingJazz Pharmaceuticals

    $50K

    Reported 07/20

  • Jazz Pharmaceuticals

    LobbyingJazz Pharmaceuticals

    $50K

    Reported 07/20

  • Jazz Pharmaceuticals

    LobbyingJazz Pharmaceuticals

    $50K

    Reported 07/19

Jazz Pharmaceuticals JAZZ paid Avenue Solutions $80K for lobbying in Q2 2023 · Health Issues, Medicare | Whalegun